Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

Anti-CD20 therapies have demonstrated considerable efficacy in the treatment of relapsing multiple sclerosis, constituting a high-efficacy treatment approach for reducing relapse risk and mitigating disability progression. These therapies have been shown to strongly deplete circulating B cells and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-Or, Amit, O’Brien, Susan M., Sweeney, Michael L., Fox, Edward J., Cohen, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351586/
https://www.ncbi.nlm.nih.gov/pubmed/34370283
http://dx.doi.org/10.1007/s40263-021-00843-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351586/
https://www.ncbi.nlm.nih.gov/pubmed/34370283
http://dx.doi.org/10.1007/s40263-021-00843-8

Ejemplares similares